ExodusPoint Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,298
Closed -$578K 2158
2023
Q3
$578K Sell
10,298
-5,903
-36% -$332K 0.01% 1188
2023
Q2
$818K Sell
16,201
-28,021
-63% -$1.49M 0.01% 1179
2023
Q1
$2.41M Buy
44,222
+6,784
+18% +$396K 0.02% 802
2022
Q4
$2.34M Buy
37,438
+27,836
+290% +$1.85M 0.03% 580
2022
Q3
$676K Sell
9,602
-7,696
-44% -$531K 0.01% 1263
2022
Q2
$980K Buy
+17,298
New +$948K 0.01% 1090
2021
Q1
Sell
-290
Closed -$14K 2700
2020
Q4
$14K Buy
+290
New +$13.6K ﹤0.01% 1893
2019
Q3
Sell
-52,108
Closed -$2.13M 1700
2019
Q2
$2.13M Buy
+52,108
New +$1.47M 0.08% 147

Other funds holding AXNX

ExodusPoint Capital Management's AXNX Position: Q4 2023 in Review

ExodusPoint Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2023, closing a stake of 10,298 shares — an estimated $578K sold.

ExodusPoint Capital Management first reported a position in AXNX in Q2 2019 and held it in 8 quarters. The position peaked at $2.41M in Q1 2023. 229 funds tracked by Wall St. Rank hold AXNX as of Q4 2023.

  • ExodusPoint Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • ExodusPoint Capital Management sold 10,298 Axonics, Inc. Common Stock shares in Q4 2023, an estimated $578K.
  • ExodusPoint Capital Management first reported a position in Axonics, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • ExodusPoint Capital Management's Axonics, Inc. Common Stock position peaked at $2.41M in Q1 2023.
  • 229 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.